Salarius Pharmaceuticals Inc (NASDAQ: SLRX) closed the day trading at $0.62 up 5.96% from the previous closing price of $0.59. In other words, the price has increased by $+0.0280 from its previous closing price. On the day, 832223 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of SLRX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.02 and its Current Ratio is at 5.02. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ladenburg Thalmann on April 27, 2020, initiated with a Buy rating and assigned the stock a target price of $3.80.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLRX now has a Market Capitalization of 2.44M and an Enterprise Value of -4.68M.
Stock Price History:
Over the past 52 weeks, SLRX has reached a high of $2.68, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is 0.5971, while the 200-Day Moving Average is calculated to be 0.8100.
Shares Statistics:
Over the past 3-months, SLRX traded about 27.74K shares per day on average, while over the past 10 days, SLRX traded about 118.71k shares per day. A total of 3.94M shares are outstanding, with a floating share count of 3.65M. Insiders hold about 7.38% of the company’s shares, while institutions hold 6.67% stake in the company. Shares short for SLRX as of Feb 29, 2024 were 18.01k with a Short Ratio of 0.65, compared to 8.26k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.46% and a Short% of Float of 0.47%.
Earnings Estimates
Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of -$1.01 for the current quarter, with a high estimate of -$1.01 and a low estimate of -$1.01, while EPS last year was -$2.83. The consensus estimate for the next quarter is -$1.15, with high estimates of -$1.15 and low estimates of -$1.15.
Analysts are recommending an EPS of between -$5.32 and -$5.32 for the fiscal current year, implying an average EPS of -$5.32. EPS for the following year is -$4.63, with 1 analysts recommending between -$4.63 and -$4.63.
